Boris is an associate in the Intellectual Property practice group. He advises clients on all matters related to intellectual property, including patent law, trademark and design protection, as well as copyright issues.
Verabschiedung der EU-Durchführungsverordnung (EU) 2025/2086: Neue Regeln zur gemeinsamen klinischen Bewertung von Medizinprodukten und In-vitro-Diagnostika
